Genome‐Wide Association Study of NAFLD Using Electronic Health Records-Reference-Cited by-同舟云学术

Genome‐Wide Association Study of NAFLD Using Electronic Health Records

Published:2021-09-17 Issue:2 Volume:6 Page:297-308
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Fairfield Cameron J.¹^ORCID,Drake Thomas M.¹,Pius Riinu¹,Bretherick Andrew D.²,Campbell Archie¹³⁴,Clark David W.⁵,Fallowfield Jonathan A.⁶^ORCID,Hayward Caroline²,Henderson Neil C.⁶^ORCID,Joshi Peter K.⁵,Mills Nicholas L.⁷,Porteous David J.³,Ramachandran Prakash⁶,Semple Robert K.⁷,Shaw Catherine A.¹,Sudlow Cathie L.M.¹,Timmers Paul R.H.J.²⁵,Wilson James F.²⁵,Wigmore Stephen J.⁸,Harrison Ewen M.¹⁸,Spiliopoulou Athina⁵

Affiliation:

1. Centre for Medical Informatics Usher InstituteUniversity of Edinburgh Edinburgh Scotland

2. MRC Human Genetics Unit Institute of Genetics and Cancer University of Edinburgh Edinburgh Scotland

3. Centre for Genomic and Experimental Medicine Institute of Genetics & Molecular Medicine University of Edinburgh Edinburgh Scotland

4. Health Data Research UK University of Edinburgh Edinburgh Scotland

5. Centre for Global Health ResearchUsher InstituteUniversity of Edinburgh Edingburgh Scotland

6. Centre for Inflammation Research Queen’s Medical Research InstituteUniversity of Edinburgh Edingburgh Scotland

7. Centre for Cardiovascular Science Queen’s Medical Research InstituteUniversity of Edinburgh Edingburgh Scotland

8. Department of Clinical Surgery Division of Health Sciences University of Edinburgh Edingburgh Scotland

Funder

Medical Research Council

Wellcome Trust

Scottish Funding Council

Chief Scientist Office

British Heart Foundation

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1805

Reference52 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges

3. Genetic predisposition in nonalcoholic fatty liver disease

4. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

5. Genome-Wide Association Study Identifies Variants Associated With Histologic Features of Nonalcoholic Fatty Liver Disease

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods;Scientific Reports;2024-02-01

2. A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver;2024-01-27

3. Human APOE4 Protects High-Fat and High-Sucrose Diet Fed Targeted Replacement Mice against Fatty Liver Disease Compared to APOE3;Aging and disease;2024

4. Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocol;Therapeutic Advances in Endocrinology and Metabolism;2024-01

5. Non-alcoholic fatty liver disease and colorectal adenoma/polyps: A Two-Sample Mendelian randomization study.;2023-12-29